291 related articles for article (PubMed ID: 31867071)
1. Radioembolization for the Treatment of Primary and Metastatic Liver Cancers.
Lee EJ; Chung HW; Jo JH; So Y
Nucl Med Mol Imaging; 2019 Dec; 53(6):367-373. PubMed ID: 31867071
[TBL] [Abstract][Full Text] [Related]
2. Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
Boas FE; Bodei L; Sofocleous CT
J Nucl Med; 2017 Sep; 58(Suppl 2):104S-111S. PubMed ID: 28864605
[TBL] [Abstract][Full Text] [Related]
3.
Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
[TBL] [Abstract][Full Text] [Related]
4. SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers.
Golfieri R
Hepat Oncol; 2014 Jun; 1(3):265-283. PubMed ID: 30190962
[TBL] [Abstract][Full Text] [Related]
5. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
[TBL] [Abstract][Full Text] [Related]
6. (90)Y-glass microspheres for hepatic neoplasia.
Mahnken AH
Future Oncol; 2015; 11(9):1343-54. PubMed ID: 25952780
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
9. Radioembolization of hepatic tumors.
Kennedy A
J Gastrointest Oncol; 2014 Jun; 5(3):178-89. PubMed ID: 24982766
[TBL] [Abstract][Full Text] [Related]
10. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
Herzer K; Müller S; Antoch G; Hilgard P
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
[TBL] [Abstract][Full Text] [Related]
11. Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver.
Lewandowski RJ; Salem R
Semin Intervent Radiol; 2006 Mar; 23(1):64-72. PubMed ID: 21326721
[TBL] [Abstract][Full Text] [Related]
12. Radioembolization for hepatocellular carcinoma: what clinicians need to know.
Choi JW; Kim HC
J Liver Cancer; 2022 Mar; 22(1):4-13. PubMed ID: 37383534
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
[TBL] [Abstract][Full Text] [Related]
14. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
[TBL] [Abstract][Full Text] [Related]
15. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
[TBL] [Abstract][Full Text] [Related]
16. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
17. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
[TBL] [Abstract][Full Text] [Related]
18. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
19. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.
Kuei A; Saab S; Cho SK; Kee ST; Lee EW
World J Gastroenterol; 2015 Jul; 21(27):8271-83. PubMed ID: 26217079
[TBL] [Abstract][Full Text] [Related]
20. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG
J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
